Financials Oceania Healthcare Limited Australian S.E.

Equities

Market Closed - Australian S.E. Other stock markets 12:06:17 2024-04-26 am EDT			5-day change	1st Jan Change
0.55 ^AUD	+1.85%		0.00%	-15.71%

Apr. 15	Oceania Healthcare Sales Increase 20%, Resales Rise 14% in 12 Months to March 31	MT
Feb. 26	New Zealand Shares Flat Ahead of Central Bank Meeting; Oceania Healthcare CEO to Step Down	MT

Fiscal Period: March	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	616.4	424.3	878.2	745.7	526	427.3	-	-
Enterprise Value (EV) ¹	864.6	746.3	878.2	1,116	1,081	1,053	1,041	1,037
P/E ratio	13.5 x	-31.4 x	9.28 x	12.1 x	33.2 x	6.28 x	6.31 x	6.51 x
Yield	4.65%	5.07%	-	4.19%	4.38%	2.05%	3.97%	6.44%
Capitalization / Revenue	3.25 x	2.19 x	-	3.23 x	2.13 x	1.5 x	1.47 x	1.35 x
EV / Revenue	4.56 x	3.86 x	-	4.83 x	4.37 x	3.69 x	3.58 x	3.29 x
EV / EBITDA	13.7 x	11.8 x	-	14.6 x	13.5 x	12.4 x	10.2 x	9.26 x
EV / FCF	-	-	-	-9,851,707 x	-	-	-	-
FCF Yield	-	-	-	-0%	-	-	-	-
Price to Book	1.01 x	0.72 x	-	0.79 x	0.55 x	0.41 x	0.39 x	0.36 x
Nbr of stocks (in thousands)	610,255	614,892	686,112	710,205	720,555	724,155	-	-
Reference price ²	1.010	0.6900	1.280	1.050	0.7300	0.5900	0.5900	0.5900
Announcement Date	7/24/19	7/22/20	5/21/21	5/19/22	5/23/23	-	-	-

¹NZD in Million²NZD

Estimates

Fiscal Period: March	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	189.4	193.6	-	231.1	247.2	285.6	291.2	315.6
EBITDA ¹	63.22	63.5	-	76.24	80.02	85.02	102.1	112
EBIT ¹	53.67	49	-	57.62	62.09	66.55	86.42	92.07
Operating Margin	28.34%	25.31%	-	24.93%	25.12%	23.3%	29.68%	29.18%
Earnings before Tax (EBT)	31.8	-28.3	-	-	-	-	-	-
Net income ¹	45.37	-13.6	85.53	61.13	15.45	75.43	74.86	82.51
Net margin	23.96%	-7.02%	-	26.45%	6.25%	26.41%	25.71%	26.15%
EPS ²	0.0750	-0.0220	0.1380	0.0870	0.0220	0.0940	0.0934	0.0906
Free Cash Flow	-	-	-	-113.3	-	-	-	-
FCF margin	-	-	-	-49.01%	-	-	-	-
FCF Conversion (EBITDA)	-	-	-	-	-	-	-	-
FCF Conversion (Net income)	-	-	-	-	-	-	-	-
Dividend per Share ²	0.0470	0.0350	-	0.0440	0.0320	0.0121	0.0234	0.0380
Announcement Date	7/24/19	7/22/20	5/21/21	5/19/22	5/23/23	-	-	-

¹NZD in Million²NZD

Estimates

Fiscal Period: March	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	248	322	-	370	555	626	614	609
Net Cash position ¹	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	3.926 x	5.072 x	-	4.858 x	6.937 x	7.358 x	6.013 x	5.443 x
Free Cash Flow	-	-	-	-113	-	-	-	-
ROE (net income / shareholders' equity)	8.75%	7.12%	-	6.86%	6.13%	5.54%	6.59%	6.81%
ROA (Net income/ Total Assets)	3.94%	2.91%	-	3%	2.47%	2.22%	2.73%	2.84%
Assets ¹	1,151	-467.3	-	2,040	625.4	3,393	2,738	2,905
Book Value Per Share ²	1.000	0.9600	-	1.340	1.340	1.440	1.530	1.630
Cash Flow per Share ²	0.1500	0.1600	-	0.1500	0.1000	0.1100	0.1500	0.1600
Capex ¹	154	136	-	113	220	202	180	187
Capex / Sales	81.2%	70.22%	-	48.67%	88.84%	70.56%	61.98%	59.13%
Announcement Date	7/24/19	7/22/20	5/21/21	5/19/22	5/23/23	-	-	-

¹NZD in Million²NZD

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.59 NZD

Average target price

0.9325 NZD

Spread / Average Target

+58.05%

	1st Jan change	Capi.
CVS HEALTH CORPORATION	-14.92%	84.68B
HCA HEALTHCARE, INC.	+13.30%	81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+10.92%	29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-12.71%	16.73B
FRESENIUS SE & CO. KGAA	-3.06%	16.36B
QUEST DIAGNOSTICS INCORPORATED	-2.63%	14.92B
PURE HEALTH HOLDING	-31.75%	11.77B
FRESENIUS MEDICAL CARE AG	-1.42%	11.72B
DAVITA INC.	+27.44%	11.71B